{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A randomized phase 3 trial of fludarabine\/cytarabine\/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomized-phase-3-trial-of-fludarabine-cytarabine-gemtuzumab-ozogamicin-with-or-without-venetoclax-in-children-with-relapsed-aml\/#breadcrumbitem"}]}